Net product sales -- $521 million for 2025, comprised of $245 million Livmarli U.S., $115 million Livmarli international, and $161 million from bile acid medicines; total exceeded prior guidance range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results